Latest Clinical trials biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Un ensayo investiga por primera vez cómo combatir el lupus del riñón con terapia génica y CAR-T

by Fundación Jiménez Díaz

2 years ago
terapia génica y CAR-T, Lupus

El objetivo del proyecto es emplear terapia génica junto con células CAR-T, un tipo de terapia inmunológica que utiliza células T del propio paciente modificadas genéticamente en un laboratorio, ...

VHIO-led FRESCO-2 phase 3 trial leads to approval from EMA for the first novel targeted therapy for metastatic colorectal cancer in over a decade

by VHIO

2 years ago
fruquintinib, metastatic colorectal cancer (mCRC), endothelial growth factor (VEGF)

Announced by the European Medicines Agency (EMA) last month, June 21, the highly selective and potent VEGFR inhibitor fruquintinib has been approved as the first novel targeted therapy in the EU for m...

AGC Pharma Chemicals y AbilityPharma trabajan juntos en la producción de un tratamiento innovador para el cáncer de páncreas

by AbilityPharma

2 years ago
principio activo farmacéutico (API), ABTL081, AbilityPharma, Pharma Chemicals, AGC Pharma Chemicals

Con este acuerdo, la biofarmacéutica española AbilityPharma inicia la fabricación de su fármaco principal ABTL0812 para administrar a pacientes con cáncer de páncreas en el marco del ensayo clí...

ORYZON renueva su compromiso con la Alianza para la Vacunación Infantil

by Oryzon Genomics

2 years ago

Oryzon suma su apoyo a la lucha contra la mortalidad infantil y contribuye al ODS 3 relativo a salud y bienestar promovido por las Naciones Unidas

The immunopathology unit of IDIVAL delves into the effectiveness of certain treatments for patients with giant cell arteritis

by Instituto de Investigación Marqués de Valdecilla

2 years ago
giant cell arteritis (GCA), inhibitors of janus kinases (iJAK), tocilizumab, aortitis

Two new publications show results on the effectiveness of inhibitors of janus kinases (iJAK) in giant cell arteritis (GCA) and on the effectiveness of the antibody tocilizumab for aortitis in GCA.

Researchers from ibs.GRANADA demonstrate the effectiveness of an intervention in the recovery of older people with hip fractures and their caregivers

by Instituto de Investigación Biosanitaria - Ibs Granada

2 years ago
ActiveHip+

This randomized clinical trial, published in the journal eClinicalMedicine, a journal of TheLancet family, is part of the Activating Older People After a Hip Fracture (ActiveHip+) project, funded with...

A Vall d'Hebron study highlights the potential of probiotics and prebiotics to control irritability due to ADHD and Borderline Personality Disorder

by Vall d’Hebron

This study provides promising preliminary evidence for the use of synbiotics in the treatment of irritability and other emotional symptoms in adults with ADHD and BPD

Arranca el ensayo clínico HistSHOCK para mejorar el diagnóstico, manejo y pronóstico de la sepsis

by INCLIVA

2 years ago
HistSHOCK, sepsis

El ensayo evaluará la eficacia y fiabilidad de la herramienta HistSHOCK DIV en el entorno clínico de cuidados intensivos y preparará el expediente técnico para su presentación en la UE, con vista...

Clinical trial of artificial intelligence software to detect lung cancer in unreported X-rays begins

by Instituto de Investigación e Innovación Parc Taulí

2 years ago
Optimal XR, lung cancer

This tool, named Optimal XR, aims to prevent potentially malignant lung nodules that are currently not diagnosed in time from continuing to go unnoticed

Cytoki Pharma Announces Positive Phase 1 Data Showing Potential of CK-0045 to Improve Cardiometabolic Risk Factors

by Ysios Capital

2 years ago
CK-0045, lipidated IL-22, Cytoki Pharma

CK-0045 induced exposure-dependent reductions in body weight and improvement of key metabolic parameters in participants with obesity

Peaches Biotech crea su propia fábrica para producir sus terapias avanzadas

by Peaches Biotech

2 years ago
Histokine, Peaches Biotech

Esta alianza se fundamenta en la especificidad del producto ya que se trata de un secretoma selectivo, un producto nuevo a nivel industrial para el que no hay todavía plantas en España para su fabri...

Thermo Fisher Scientific Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS, a Precursor to Multiple Myeloma

by Thermo Fisher Scientific

2 years ago
Multiple Myeloma, monoclonal gammopathy of undetermined significance (MGUS)

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite® Fre...